These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31143317)

  • 1.
    Frank T; Farra A; Rubbo PA; Mbecko JR; Sanke H; Le Flèche-Matéos A; Lombart JP; Berlioz-Arthaud A
    Pan Afr Med J; 2019; 32():12. PubMed ID: 31143317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rare case of community acquired Burkholderia cepacia infection presenting as pyopneumothorax in an immunocompetent individual.
    Karanth SS; Regunath H; Chawla K; Prabhu M
    Asian Pac J Trop Biomed; 2012 Feb; 2(2):166-8. PubMed ID: 23569891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Arthritis caused by Burkholderia cepacia].
    Rodríguez MS; de la Fuente J; Montero J; Rodríguez MI
    Enferm Infecc Microbiol Clin; 2010 Apr; 28(4):258-9. PubMed ID: 19783076
    [No Abstract]   [Full Text] [Related]  

  • 4. Community-acquired Burkholderia cepacia pneumonia: a report of two immunocompetent patients.
    Bayram M; Babalık M; Bakan ND; Döngel I
    Tuberk Toraks; 2011; 59(4):380-3. PubMed ID: 22233309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of patients with Burkholderia cepacia bacteremia.
    Huang CH; Jang TN; Liu CY; Fung CP; Yu KW; Wong WW
    J Microbiol Immunol Infect; 2001 Sep; 34(3):215-9. PubMed ID: 11605815
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Ibrahim M; Yap JY
    BMJ Case Rep; 2018 Apr; 2018():. PubMed ID: 29695396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activities of antimicrobial agents, alone and in combinations, against Burkholderia cepacia isolated from blood.
    Lu DC; Chang SC; Chen YC; Luh KT; Hsieh WC
    Diagn Microbiol Infect Dis; 1997 Aug; 28(4):187-91. PubMed ID: 9327247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Meningoencephalitis caused by Pseudomonas cepacia].
    Pérez Monrás MF; Batlle Almodóvar Mdel C; González C; Tamargo Martínez I; Meneses FD
    Rev Cubana Med Trop; 2006; 58(2):162-4. PubMed ID: 23427437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An opportunistic pathogen frequently isolated from immunocompromised patients: Burkholderia cepacia complex].
    Baylan O
    Mikrobiyol Bul; 2012 Apr; 46(2):304-18. PubMed ID: 22639321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parotitis due to Burkholderia cepacia infection after autologous hematopoietic stem cell transplantation.
    Xu H; Yang Y; Yan J; Huang D; Liu X
    Transpl Infect Dis; 2020 Dec; 22(6):e13374. PubMed ID: 32564412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endemic burkholderia cepacia bacteraemia: clinical features and antimicrobial susceptibilities of isolates.
    Yu WL; Wang DY; Lin CW; Tsou MF
    Scand J Infect Dis; 1999; 31(3):293-8. PubMed ID: 10482060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of three oligonucleotide primer sets in PCR for the identification of Burkholderia cepacia and their differentiation from Burkholderia gladioli.
    Clode FE; Kaufmann ME; Malnick H; Pitt TL
    J Clin Pathol; 1999 Mar; 52(3):173-6. PubMed ID: 10450174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival following Burkholderia cepacia sepsis in a patient with cystic fibrosis treated with corticosteroids.
    Kazachkov M; Lager J; LiPuma J; Barker PM
    Pediatr Pulmonol; 2001 Oct; 32(4):338-40. PubMed ID: 11568995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burkholderia Sepsis in Children as a Hospital-Acquired Infection.
    Kim KY; Yong D; Lee K; Kim HS; Kim DS
    Yonsei Med J; 2016 Jan; 57(1):97-102. PubMed ID: 26632388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burkholderia cepacia endophthalmitis: clinico-microbiologic profile and outcomes.
    Sachdeva V; Pathengay A; Joseph J; Sharma S; Das T
    Retina; 2011 Oct; 31(9):1801-5. PubMed ID: 21478807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burkholderia cepacia septicemia in a pediatric oncology patient: a pharmacotherapy challenge.
    Durham SH; Lee AE; Assanasen C
    Ann Pharmacother; 2012 Jun; 46(6):e16. PubMed ID: 22570430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Misidentification of Burkholderia pseudomallei as Burkholderia cepacia by the VITEK 2 system.
    Zong Z; Wang X; Deng Y; Zhou T
    J Med Microbiol; 2012 Oct; 61(Pt 10):1483-1484. PubMed ID: 22820689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Burkholderia cepacia: a new pathogen causing nosocomial infections].
    Lipowski D; Rzadkiewicz E; Czekalska-Lachowicz E
    Przegl Epidemiol; 2008; 62(1):7-17. PubMed ID: 18536220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burkholderia cepacia sepsis among neonates.
    Patra S; Bhat Y R; Lewis LE; Purakayastha J; Sivaramaraju VV; Kalwaje E V; Mishra S
    Indian J Pediatr; 2014 Nov; 81(11):1233-6. PubMed ID: 24871076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of bacteraemia caused by Burkholderia cepacia complex species and antimicrobial susceptibility of the isolates in a medical centre in Taiwan.
    Chien YC; Liao CH; Sheng WH; Chien JY; Huang YT; Yu CJ; Hsueh PR
    Int J Antimicrob Agents; 2018 Mar; 51(3):357-364. PubMed ID: 28705667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.